Inventor · disambiguated record
Daniel Hoth
Also filed as: HOTH DANIEL
0 granted patents·11 pending applications·0 citations·filing 2006–2006
Top patents by PatentIndex Score
11 records- 0155US2007010465A1Zosuquidar, daunorubicin, and cytarabine for the treatment of cancerSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0255US2007010466A1Zosuquidar, daunorubicin, and cytarabine for the treatment of cancerSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0355US2007010478A1Zosuquidar, daunorubicin, and cytarabine for the treatment of cancerSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0452US2007009532A1Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidarSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0552US2007009531A1Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidarSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0645US2007010485A1Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrinsSCHWEGMAN JEFF·Filed 2006·Application pending·0 cites
- 0745US2007010487A1Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrinsSCHWEGMAN JEFF·Filed 2006·Application pending·0 cites
- 0845US2007010486A1Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrinsSCHWEGMAN JEFF·Filed 2006·Application pending·0 cites
- 0944US2007009533A1Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanismSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 1043US2007009534A1Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanismSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 1136US2007009535A1Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanismSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Hoth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →